Amrad and Merck in Deal to Develop New Asthma Drugs

By Business Review Editor

Pharma Deals Review: Vol 2003 Issue 38 (Table of Contents)

Published: 3 Jul-2003

DOI: 10.3833/pdr.v2003.i38.879     ISSN: 1756-7874

Section: Research & Development

Abstract

Amrad and Merck Sharp & Dohme entered into multi-year research collaboration and exclusive licensing terms for the investigation and commercialization of drug candidates with therapeutic potential for asthma and other respiratory diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details